Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

Andres Wiernik; Wolfgang R. Sperr; Daniel Weisdorf; Peter Valent; Celalettin Ustun

doi:10.1002/ajh.23440

Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

Andres Wiernik
, Wolfgang R. Sperr
, Daniel Weisdorf
, Peter Valent
, Celalettin Ustun

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	533-534
Number of pages	2
Journal	American Journal of Hematology
Volume	88
Issue number	6
DOIs	https://doi.org/10.1002/ajh.23440
State	Published - Jun 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1002/ajh.23440

Find It

Find It at U of M Libraries

Cite this

@article{53db7ef51bd9408a814a59dc330a3ba2,

title = "Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?",

author = "Andres Wiernik and Sperr, \{Wolfgang R.\} and Daniel Weisdorf and Peter Valent and Celalettin Ustun",

year = "2013",

month = jun,

doi = "10.1002/ajh.23440",

language = "English (US)",

volume = "88",

pages = "533--534",

journal = "American Journal of Hematology",

issn = "0361-8609",